49 related articles for article (PubMed ID: 34582360)
1. Metformin and pancreatic neuroendocrine tumors: A systematic review and meta-analysis.
Cigrovski Berkovic M; Coppola A; Sesa V; Mrzljak A; Lai Q
World J Gastroenterol; 2024 Feb; 30(7):759-769. PubMed ID: 38515954
[TBL] [Abstract][Full Text] [Related]
2. Translational Potential of a Contrast Agent for FGS Applications in pNETs.
AghaAmiri S; Estrella JS; Vargas SH; Hurd MW; Ghosh SC; Azhdarinia A; Ikoma N
Mol Imaging Biol; 2024 Apr; 26(2):191-194. PubMed ID: 38267640
[No Abstract] [Full Text] [Related]
3. Preoperative risk stratification of lymph node metastasis for non-functional pancreatic neuroendocrine neoplasm: An international dual-institutional study.
Kasai Y; Masui T; Nakakura EK; Nakano K; Sato A; Uchida Y; Yogo A; Nagai K; Anazawa T; Hope TA; Kim GE; Whitman J; Le BK; Takaori K; Bergsland EK; Hatano E; Uemoto S
Pancreatology; 2022 Jan; 22(1):123-129. PubMed ID: 34736838
[TBL] [Abstract][Full Text] [Related]
4. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.
Ito T; Masui T; Komoto I; Doi R; Osamura RY; Sakurai A; Ikeda M; Takano K; Igarashi H; Shimatsu A; Nakamura K; Nakamoto Y; Hijioka S; Morita K; Ishikawa Y; Ohike N; Kasajima A; Kushima R; Kojima M; Sasano H; Hirano S; Mizuno N; Aoki T; Aoki T; Ohtsuka T; Okumura T; Kimura Y; Kudo A; Konishi T; Matsumoto I; Kobayashi N; Fujimori N; Honma Y; Morizane C; Uchino S; Horiuchi K; Yamasaki M; Matsubayashi J; Sato Y; Sekiguchi M; Abe S; Okusaka T; Kida M; Kimura W; Tanaka M; Majima Y; Jensen RT; Hirata K; Imamura M; Uemoto S
J Gastroenterol; 2021 Nov; 56(11):1033-1044. PubMed ID: 34586495
[TBL] [Abstract][Full Text] [Related]
5. Progress in the Management of Pancreatic Neuroendocrine Tumors.
Chang A; Sherman SK; Howe JR; Sahai V
Annu Rev Med; 2022 Jan; 73():213-229. PubMed ID: 34669433
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin analogs in patients with Zollinger Ellison syndrome (ZES): an observational study.
Massironi S; Cavalcoli F; Elvevi A; Quatrini M; Invernizzi P
Endocrine; 2022 Mar; 75(3):942-948. PubMed ID: 34716542
[TBL] [Abstract][Full Text] [Related]
7. Patterns and predictors of pancreatic neuroendocrine tumor prognosis: Are no two leaves alike?
Gao H; Wang W; Yu X; Liu L
Crit Rev Oncol Hematol; 2021 Nov; 167():103493. PubMed ID: 34653597
[TBL] [Abstract][Full Text] [Related]
8. Incidence and Predictors of Second Primary Cancers in Patients With Neuroendocrine Tumors.
Bateni SB; Coburn NG; Law CHL; Singh S; Myrehaug S; Assal A; Hallet J
JAMA Oncol; 2021 Nov; 7(11):1718-1720. PubMed ID: 34591069
[TBL] [Abstract][Full Text] [Related]
9. Status of Surveillance and Nonsurgical Therapy for Small Nonfunctioning Pancreatic Neuroendocrine Tumors.
van Beek DJ; Verschuur AVD; Brosens LAA; Valk GD; Pieterman CRC; Vriens MR
Surg Oncol Clin N Am; 2023 Apr; 32(2):343-371. PubMed ID: 36925190
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers for prognosis in pancreatic neuroendocrine tumors.
Zhu M; Sorenson KR; Liu R; Gould Rothberg BE; Halfdanarson TR
Endocr Relat Cancer; 2021 Oct; 28(12):773-782. PubMed ID: 34582360
[TBL] [Abstract][Full Text] [Related]
11. Preoperative acute pancreatitis and hyperenzymemia are associated with poor prognosis in patients with nonfunctional pancreatic neuroendocrine tumors.
Song H; Tan Q; Yuan Y; Liu X; Chen Y; Wang X
J Surg Oncol; 2023 Jun; 127(7):1135-1142. PubMed ID: 36912877
[TBL] [Abstract][Full Text] [Related]
12. The incidence, prevalence, and survival analysis of pancreatic neuroendocrine tumors in the United States.
Liu X; Chen B; Chen J; Su Z; Sun S
J Endocrinol Invest; 2023 Jul; 46(7):1373-1384. PubMed ID: 36522587
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of CT characteristics in GEP-NET: A systematic review.
van der Velden DL; Staal FCR; Aalbersberg EA; Castagnoli F; Wilthagen E; Beets-Tan RGH
Crit Rev Oncol Hematol; 2022 Jul; 175():103713. PubMed ID: 35598829
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological trends for functional pancreatic neuroendocrine tumors: A study combining multiple imputation with age adjustment.
Luo S; Wang J; Wu L; Wang C; Yang J; Li M; Zhang L; Ge J; Sun C; Li E; Lei J; Liao Y; Zhou F; Liao W
Front Endocrinol (Lausanne); 2023; 14():1123642. PubMed ID: 37113484
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
